ALCAM and prostate carcinoma: Indeed, ALCAM has been implicated in the progression and metastasis of cutaneous melanoma [25], prostate carcinoma [26], [27], breast cancer [28]–[30], colorectal carcinoma [31], bladder cancer [32], and esophageal squamous cell cancer [33], among others (for review see ref. [5]).